Belgium: Gimv strengthens position in life sciences venture capital with new platform

Euronext Brussels listed Gimv, a European investment company, has created its fifth investment platform. The platform will focus on venture capital investment opportunities in life sciences companies. After solid growth within Gimv’s existing Healthcare platform, a dedicated Life Sciences platform will strengthen the role of Gimv in the international life science VC ecosystem. The key…

You must be a HMI Subscriber to view this content.

Subscribe Now »